ENDOMETRIAL NEOPLASMS
Clinical trials for ENDOMETRIAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL NEOPLASMS trials appear
Sign up with your email to follow new studies for ENDOMETRIAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to shrink hard-to-treat HER2 cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called BL-M17D1 in 120 adults with advanced solid tumors that have HER2 changes (either too much HER2 protein or a HER2 gene mutation). The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participa…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New combo therapy targets Hard-to-Treat cancers
Disease control OngoingThis study tests a new drug called E7386 combined with other anticancer drugs for people with advanced solid tumors, including endometrial, liver, and colorectal cancers. The main goals are to find safe doses and see if the combination shrinks tumors. About 301 adults will take p…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New drug combo shows promise in slowing endometrial cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy, followed by maintenance therapy with or without the targeted drug olaparib, can help people with newly diagnosed advanced or recurrent endometrial cancer live longer without their cancer g…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC